Clinical correlation and prognostic value of xanthine and inflammatory factors in postpartum depression
Abstract
Objectives: As a common postpartum complication, postpartum depression is an important social and health problem. Postpartum depression causes many changes in relevant indicators, such as inflammatory factors and thyroid hormones. However, the effects of inflammatory factors, thyroid hormones and xanthine on postpartum depression have not yet been fully elucidated. Therefore, it is of great clinical significance to clarify the changes in the key indicators of postpartum depression.
Material and methods: A total of 139 pregnant women were included in this study. Finally, only 56 patients completed the Edinburgh Depression Scale (EPDS) evaluation and blood sample collection.
Results: In the current study, 34 (60.7%) patients were normal, 10 (17.9%) women were depressive tendency and 12 (21.4%) women developed depression. Among the serum indexes detected, the expression levels of thyroid function indexes T3, T4 and TSH, and inflammatory factors, such as hs-CRP, IL-1β, IL-6 and TNF-α, in the EPDS ≥ 9 group were slightly higher than those in the normal group (EPDS < 9). Xanthine levels in the depression group (EPDS ≥ 13) were significantly higher than normal group (EPDS < 9).
Conclusions: Our findings suggest that xanthine levels in patients with postpartum depression were increased significantly, but there were no significant changes in thyroid function and some inflammatory indexes. Therefore, timely detection and intervention of maternal xanthine may help reduce the incidence of postpartum depression.
Keywords: postpartum depressionEDSthyroid functioninflammatory factorsxanthineIL-6EPDS
References
- Drevets WC, Wittenberg GM, Bullmore ET, et al. Immune targets for therapeutic development in depression: towards precision medicine. Nat Rev Drug Discov. 2022; 21(3): 224–244.
- Bangasser DA, Cuarenta A. Sex differences in anxiety and depression: circuits and mechanisms. Nat Rev Neurosci. 2021; 22(11): 674–684.
- Wang F, Zhu H, Yang X, et al. Effects of internet-based cognitive behavioral therapy on postpartum depression: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2022; 101(9): e28964.
- Weingarten S, Diop S, Specht C, et al. Differences in interactional behaviour in postpartum depression with and without pre-existing mental disorder. Compr Psychiatry. 2021; 108: 152248.
- Huang X, Luo S, Wang H. Effects of the non-pharmacological interventions of traditional Chinese medicine on postpartum depression: A protocol for systematic review and network meta-analysis. Medicine (Baltimore). 2022; 101(9): e28939.
- Opie RS, Uldrich AC, Ball K. Maternal postpartum diet and postpartum depression: a systematic review. Matern Child Health J. 2020; 24(8): 966–978.
- Anokye R, Acheampong E, Budu-Ainooson A, et al. Prevalence of postpartum depression and interventions utilized for its management. Ann Gen Psychiatry. 2018; 17: 18.
- Edvinsson Å, Skalkidou A, Hellgren C, et al. Different patterns of attentional bias in antenatal and postpartum depression. Brain Behav. 2017; 7(11): e00844.
- Worthen RJ, Beurel E. Inflammatory and neurodegenerative pathophysiology implicated in postpartum depression. Neurobiol Dis. 2022; 165: 105646.
- Zeng Q, Wang XH, Yang LP, et al. Shengxuening oral iron supplementation for the treatment of renal anemia: a systematic review. J Transl Int Med. 2020; 8(4): 245–254.
- Semiz A, Ozgun Acar O, Cetin H, et al. Suppression of inflammatory cytokines expression with bitter melon () in tnbs-instigated ulcerative colitis. J Transl Int Med. 2020; 8(3): 177–187.
- Raghupathy R, Kalinka J. Cytokine imbalance in pregnancy complications and its modulation. Front Biosci. 2008; 13: 985–994.
- Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010; 67(5): 446–457.
- Blackmore ER, Moynihan JA, Rubinow DR, et al. Psychiatric symptoms and proinflammatory cytokines in pregnancy. Psychosom Med. 2011; 73(8): 656–663.
- Leff-Gelman P, Mancilla-Herrera I, Flores-Ramos M, et al. The immune system and the role of inflammation in perinatal depression. Neurosci Bull. 2016; 32(4): 398–420.
- Simpson W, Steiner M, Coote M, et al. Relationship between inflammatory biomarkers and depressive symptoms during late pregnancy and the early postpartum period: a longitudinal study. Braz J Psychiatry. 2016; 38(3): 190–196.
- Shelton MM, Schminkey DL, Groer MW. Relationships among prenatal depression, plasma cortisol, and inflammatory cytokines. Biol Res Nurs. 2015; 17(3): 295–302.
- Konstantakou P, Chalarakis N, Valsamakis G, et al. Associations of thyroid hormones profile during normal pregnancy and postpartum with anxiety, depression, and obsessive/compulsive disorder scores in euthyroid women. Front Neurosci. 2021; 15: 663348.
- Szpunar MJ, Parry BL. A systematic review of cortisol, thyroid-stimulating hormone, and prolactin in peripartum women with major depression. Arch Womens Ment Health. 2018; 21(2): 149–161.
- Groer MW, Vaughan JH. Positive thyroid peroxidase antibody titer is associated with dysphoric moods during pregnancy and postpartum. J Obstet Gynecol Neonatal Nurs. 2013; 42(1): E26–E32.
- Andersen SL, Knøsgaard L, Handberg A, et al. Maternal adiposity, smoking, and thyroid function in early pregnancy. Endocr Connect. 2021; 10(9): 1125–1133.
- Wang JW, Liao XX, Li T. Thyroid autoimmunity in adverse fertility and pregnancy outcomes: timing of assisted reproductive technology in AITD women. J Transl Int Med. 2021; 9(2): 76–83.
- Fan KQ, Li YY, Wang HL, et al. Stress-Induced metabolic disorder in peripheral CD4 t cells leads to anxiety-like behavior. Cell. 2019; 179(4): 864–879.e19.
- Norhayati MN, Hazlina NH, Asrenee AR, et al. Magnitude and risk factors for postpartum symptoms: a literature review. J Affect Disord. 2015; 175: 34–52.
- Gastaldon C, Solmi M, Correll CU, et al. Risk factors of postpartum depression and depressive symptoms: umbrella review of current evidence from systematic reviews and meta-analyses of observational studies. Br J Psychiatry. 2022; 221(4): 591–602.
- Mammenga E, Hansen KA. Complementary and alternative treatments for perinatal depression. S D Med. 2021; 74(11): 506–512.
- Marconcin P, Peralta M, Gouveia ÉR, et al. Effects of exercise during pregnancy on postpartum depression: a systematic review of meta-analyses. Biology (Basel). 2021; 10(12).
- Clare CA, Yeh J. Postpartum depression in special populations: a review. Obstet Gynecol Surv. 2012; 67(5): 313–323.
- Zhao L, Chen J, Lan L, et al. Effectiveness of telehealth interventions for women with postpartum depression: systematic review and meta-analysis. JMIR Mhealth Uhealth. 2021; 9(10): e32544.
- Navarro P, Ascaso C, Garcia-Esteve L, et al. Postnatal psychiatric morbidity: a validation study of the GHQ-12 and the EPDS as screening tools. Gen Hosp Psychiatry. 2007; 29(1): 1–7.
- Masmoudi J, Charfeddine F, Trabelsi S, et al. [Postpartum depression: prevalence and risk factors. A prospective Study concerning 302 Tunisian parturients]. Tunis Med. 2014; 92(10): 615–621.
- Kendall-Tackett K. A new paradigm for depression in new mothers: the central role of inflammation and how breastfeeding and anti-inflammatory treatments protect maternal mental health. Int Breastfeed J. 2007; 2: 6.
- Chao J, Cui S, Liu C, et al. Detection of early cytokine storm in patients with septic shock after abdominal surgery. J Transl Int Med. 2020; 8(2): 91–98.
